DuPont de Nemours, Inc. (DD) is a global specialty chemicals and materials company headquartered in Wilmington, Delaware. Following a series of divestitures, the company now operates through two primary segments: Healthcare & Water Technologies and Diversified Industrials. Its product portfolio spans water filtration and separation solutions, medical-device components, protective materials such as TYVEK, and engineered components for automotive, aerospace, and construction applications.
The company has been in the middle of a multi-year transformation. In late 2025 it separated its electronics business into an independent entity called Qnity and later divested its Aramids operations. The remaining, more focused DuPont is intended to be a higher-margin, less cyclical business. In June 2026 the company also completed a 1-for-3 reverse stock split, consolidating every three shares into one and lifting the per-share price into a range more typical of large-cap industrial peers.
The $170 figure is not arbitrary. According to S&P Global, the average 12-month analyst price target for DD sits at roughly $170, with a range spanning approximately $156 to $186. That makes $170 a widely followed benchmark that sits comfortably above the stock's recent trading range and its 52-week high near $158. Reaching it would require a meaningful leg higher rather than routine day-to-day movement, which is precisely why investors are focused on it.
Several factors support the case for a move toward $170. First, the portfolio reset has concentrated DuPont around businesses with stronger growth and margin profiles. Healthcare and water technologies in particular offer secular demand tied to semiconductor fabrication, life sciences, and municipal water infrastructure, rather than purely cyclical industrial cycles.
Second, management raised full-year 2026 adjusted earnings guidance to a split-adjusted range of about $7.02 to $7.16 per share, reflecting confidence in underlying execution. A steadily growing earnings base is a prerequisite for any durable re-rating.
Finally, Wall Street sentiment remains constructive. The consensus rating on DD is a "Buy," with firms such as BMO Capital and RBC Capital maintaining favorable views and price targets at or above the $170 mark. If earnings continue to beat expectations, analysts could raise targets further, reinforcing upward momentum.
The most significant risk is litigation. DuPont faces ongoing legal exposure related to PFAS, the class of so-called "forever chemicals," including class-action claims tied to firefighter turnout gear and water contamination. Large settlements or adverse rulings could pressure the share price and divert cash away from growth and shareholder returns.
Beyond litigation, DuPont remains exposed to broader industrial and construction cycles. A slowdown in non-residential construction, automotive production, or general manufacturing activity could weigh on its Diversified Industrials segment. Because the stock already trades near its 52-week high, it may also be vulnerable to profit-taking if results merely meet, rather than exceed, expectations.
From a technical standpoint, the 52-week high near $158 represents the first major resistance level. A decisive, sustained break above that zone would clear the path toward the $170 target and likely attract momentum-driven buying. On the downside, the low-$120s has acted as a support area in recent months, and a retreat below that level would signal waning conviction in the turnaround story.
Traders monitoring DD can use AI Daily Buy/Sell Signals to track shifting conditions more efficiently. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. These signals can help traders discover new opportunities, monitor existing positions, and identify emerging market trends without manually reviewing every chart. For those watching whether DuPont can build momentum toward $170, AI Daily Buy/Sell Signals offer a way to stay informed as conditions evolve.
A move to $170 for DD appears realistic but is far from guaranteed. The strongest arguments in favor are the company's higher-margin, post-divestiture portfolio, raised earnings guidance, and a supportive analyst consensus with targets clustered near that level. The primary risks are PFAS-related legal liabilities, cyclical demand in its industrial end markets, and the challenge of extending a rally that has already pushed shares near their 52-week high. Investors should monitor earnings execution, any material litigation developments, and whether the stock can clear and hold above the $158 resistance zone before the $170 objective becomes more than a target.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, DD has been closely correlated with LYB. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if DD jumps, then LYB could also see price increases.